APA (7th ed.) Citation

YJ, X., K, W., YT, Z., S, F., HM, Y., XW, L., . . . SQ, C. (2022). Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory. Frontiers in oncology, 12, 839605. https://doi.org/10.3389/fonc.2022.839605

Chicago Style (17th ed.) Citation

YJ, Xiang, et al. "Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory." Frontiers in Oncology 12 (2022): 839605. https://doi.org/10.3389/fonc.2022.839605.

MLA (9th ed.) Citation

YJ, Xiang, et al. "Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory." Frontiers in Oncology, vol. 12, 2022, p. 839605, https://doi.org/10.3389/fonc.2022.839605.